2025 Drug Shortage Guardian Award Honors Federal Heroes Who Saved Lives During IV Fluid Crisis
Agencies recognized by patient advocacy organization, Angels for Change, for swift action and lifesaving logistics following hurricanes Helene and Milton.
Angels for Change (A4C) announces the pilot launch of Project GOLD (Generic Oncology Lifesaving Drugs), a new resiliency program that establishes an onshore buffer supply of six essential medications that are used to treat cancer. Project GOLD was created to offer physicians and patients stability of care during a shortage through emergency supply at leading distributors and manufacturers. A4C is participating with founding pilot members, pharmaceutical wholesalers Cencora and McKesson, and pharmaceutical and medtech manufacturer Fresenius Kabi.
Angels for Change (A4C) announces its 2024 Change Maker of the Year Award , Lindsey Thomas, Senior Vice President of Marketing at Fresenius Kabi USA. Lindsey was recognized for her exceptional leadership, collaborative spirit, and unwavering commitment to patient care, particularly in addressing the critical chemotherapy drug shortages during 2023 and 2024.
Angels for Change announced the 2023 Change Maker of the Year Award at their 3rd Annual Champions for Change Gala on September 16th in Tampa, FL. The Change Maker of the Year award is given to an individual, a change agent, who has committed to and delivered significant change in the fight to ensure access to essential medicines for patients.
90% of the majority of medications Americans take are generics. These generics should never be in shortage, especially when patients' lives are at stake. At Angels for Change, we know there is a path forward. It is not our mission to simply help the crisis, but instill a permanent systemic change to end drug shortages.
Read our latest edition of the Changemaker Chronicle, our quarterly newsletter. Click HERE or below to see our growth in national publications, legislation, policy, patient advocacy, and upcoming events.
Parents across the US are beginning to face the struggles of a second winter without enough amoxicillin, the most prescribed antibiotic in the country.
